A PHASE II STUDY OF CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Ramy Esmat Abdelsayed Ibrahim;
Abstract
A
bout 400,000 head and neck squamous cell carcinomas (HNSCC) are diagnosed worldwide annually, most of which are locally advanced at presentation about two thirds of these cases were presented with advanced disease (Koukourakis et al., 2010).
Radiat
bout 400,000 head and neck squamous cell carcinomas (HNSCC) are diagnosed worldwide annually, most of which are locally advanced at presentation about two thirds of these cases were presented with advanced disease (Koukourakis et al., 2010).
Radiat
Other data
| Title | A PHASE II STUDY OF CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK | Authors | Ramy Esmat Abdelsayed Ibrahim | Keywords | A PHASE II STUDY OF CHEMORADIOTHERAPY PLUS C225 (CETUXIMAB) FOR LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK | Issue Date | 2011 | Description | A bout 400,000 head and neck squamous cell carcinomas (HNSCC) are diagnosed worldwide annually, most of which are locally advanced at presentation about two thirds of these cases were presented with advanced disease (Koukourakis et al., 2010). Radiat |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 104112Ramy Marsh.pdf | 70.44 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.